Skip to content

Author

Parul Srivastava

We have 2 of 14 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Machine Learning in Hyperlipidaemia Research: Screening and Experimental Insights into Lipid Metabolism Modulators.

The combination of ML and molecular docking offers an efficient and accurate platform for antihyperlipidemic drug discovery, helping to overcome the limitations of currently available therapeutic strategies.

Ashish Srivastava, Mohit Prajapati, Parul Srivastava et al. · 0 citations
Review Jul 2026

A Survey Review of Computational Models and Their Applications in Predicting Drug-Drug Interactions

An overview of how artificial intelligence might serve not only as a tool but also as a strategic solution for safe prescribing and tailored pharmacotherapy, hence opening up new avenues for the field of drug safety science is presented.

D. Tripathi, A. Wal, Vivek Kumar Gupta et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.